Literature DB >> 23264598

Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo.

Huiying Zhi1, Lubica Rauova, Vincent Hayes, Cunji Gao, Brian Boylan, Debra K Newman, Steven E McKenzie, Brian C Cooley, Mortimer Poncz, Peter J Newman.   

Abstract

The integrin family is composed of a series of 24 αβ heterodimer transmembrane adhesion receptors that mediate cell-cell and cell-extracellular matrix interactions. Adaptor molecules bearing immunoreceptor tyrosine-based activation motifs (ITAMs) have recently been shown to cooperate with specific integrins to increase the efficiency of transmitting ligand-binding-induced signals into cells. In human platelets, Fc receptor γ-chain IIa (FcγRIIa) has been identified as an ITAM-bearing transmembrane receptor responsible for mediating "outside-in" signaling through αIIbβ3, the major adhesion receptor on the platelet surface. To explore the importance of FcγRIIa in thrombosis and hemostasis, we subjected FcγRIIa-negative and FcγRIIa-positive murine platelets to a number of well-accepted models of platelet function. Compared with their FcγRIIa-negative counterparts, FcγRIIa-positive platelets exhibited increased tyrosine phosphorylation of Syk and phospholipase Cγ2 and increased spreading upon interaction with immobilized fibrinogen, retracted a fibrin clot faster, and showed markedly enhanced thrombus formation when perfused over a collagen-coated flow chamber under conditions of arterial and venous shear. They also displayed increased thrombus formation and fibrin deposition in in vivo models of vascular injury. Taken together, these data establish FcγRIIa as a physiologically important functional conduit for αIIbβ3-mediated outside-in signaling, and suggest that modulating the activity of this novel integrin/ITAM pair might be effective in controlling thrombosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23264598      PMCID: PMC3591804          DOI: 10.1182/blood-2012-07-443325

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  Topographical Association of the Platelet Fc-receptor with the Glycoprotein IIb-IIIa Complex.

Authors:  M C Berndt; A V Mazurov; D V Vinogradov; G F Burns; C N Chesterman
Journal:  Platelets       Date:  1993       Impact factor: 3.862

2.  Regulation of the protein tyrosine kinase pp72syk by platelet agonists and the integrin alpha IIb beta 3.

Authors:  E A Clark; S J Shattil; M H Ginsberg; J Bolen; J S Brugge
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

3.  Interaction of normal, thrombasthenic, and Bernard-Soulier platelets with immobilized fibrinogen: defective platelet-fibrinogen interaction in thrombasthenia.

Authors:  B S Coller
Journal:  Blood       Date:  1980-02       Impact factor: 22.113

4.  Detection of integrin alpha IIbbeta 3 clustering in living cells.

Authors:  Charito Buensuceso; Maddalena de Virgilio; Sanford J Shattil
Journal:  J Biol Chem       Date:  2003-02-20       Impact factor: 5.157

5.  In vivo fluorescence imaging of large-vessel thrombosis in mice.

Authors:  Brian C Cooley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03-10       Impact factor: 8.311

6.  Identification of signaling motifs within human Fc gamma RIIa and Fc gamma RIIb isoforms.

Authors:  I E Van den Herik-Oudijk; P J Capel; T van der Bruggen; J G Van de Winkel
Journal:  Blood       Date:  1995-04-15       Impact factor: 22.113

7.  Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets.

Authors:  Brian Boylan; Cunji Gao; Vipul Rathore; Joan C Gill; Debra K Newman; Peter J Newman
Journal:  Blood       Date:  2008-07-18       Impact factor: 22.113

8.  Analysis of the spatial and temporal characteristics of platelet-delivered factor VIII-based clots.

Authors:  Michael Neyman; Jamie Gewirtz; Mortimer Poncz
Journal:  Blood       Date:  2008-06-16       Impact factor: 22.113

9.  Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain.

Authors:  Cunji Gao; Brian Boylan; Dan Bougie; Joan C Gill; Jessica Birenbaum; Debra K Newman; Richard H Aster; Peter J Newman
Journal:  J Clin Invest       Date:  2009-02-09       Impact factor: 14.808

10.  Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo.

Authors:  Marie-Luise von Brühl; Konstantin Stark; Alexander Steinhart; Sue Chandraratne; Ildiko Konrad; Michael Lorenz; Alexander Khandoga; Anca Tirniceriu; Raffaele Coletti; Maria Köllnberger; Robert A Byrne; Iina Laitinen; Axel Walch; Alexander Brill; Susanne Pfeiler; Davit Manukyan; Siegmund Braun; Philipp Lange; Julia Riegger; Jerry Ware; Annekathrin Eckart; Selgai Haidari; Martina Rudelius; Christian Schulz; Katrin Echtler; Volker Brinkmann; Markus Schwaiger; Klaus T Preissner; Denisa D Wagner; Nigel Mackman; Bernd Engelmann; Steffen Massberg
Journal:  J Exp Med       Date:  2012-03-26       Impact factor: 14.307

View more
  36 in total

1.  Diacylglycerol kinase ζ is a negative regulator of GPVI-mediated platelet activation.

Authors:  Alyssa J Moroi; Nicole M Zwifelhofer; Matthew J Riese; Debra K Newman; Peter J Newman
Journal:  Blood Adv       Date:  2019-04-09

Review 2.  Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy.

Authors:  Michal Heger; Rowan F van Golen; Mans Broekgaarden; Renate R van den Bos; H A Martino Neumann; Thomas M van Gulik; Martin J C van Gemert
Journal:  Lasers Med Sci       Date:  2014-03       Impact factor: 3.161

3.  TC21/RRas2 regulates glycoprotein VI-FcRγ-mediated platelet activation and thrombus stability.

Authors:  S Janapati; J Wurtzel; C Dangelmaier; B K Manne; D Bhavanasi; J C Kostyak; S Kim; M Holinstat; S P Kunapuli; L E Goldfinger
Journal:  J Thromb Haemost       Date:  2018-06-08       Impact factor: 5.824

Review 4.  Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting.

Authors:  Annalisa Contursi; Angela Sacco; Rosalia Grande; Melania Dovizio; Paola Patrignani
Journal:  Cell Mol Life Sci       Date:  2017-05-09       Impact factor: 9.261

Review 5.  New Concepts and Mechanisms of Platelet Activation Signaling.

Authors:  Brian Estevez; Xiaoping Du
Journal:  Physiology (Bethesda)       Date:  2017-03

6.  Anti-miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice.

Authors:  Yuhang Zhou; Shaji Abraham; Pierrette Andre; Leonard C Edelstein; Chad A Shaw; Carol A Dangelmaier; Alexander Y Tsygankov; Satya P Kunapuli; Paul F Bray; Steven E McKenzie
Journal:  Blood       Date:  2015-10-29       Impact factor: 22.113

Review 7.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

8.  Platelets Disseminate Extracellular Vesicles in Lymph in Rheumatoid Arthritis.

Authors:  Nicolas Tessandier; Imene Melki; Nathalie Cloutier; Isabelle Allaeys; Adam Miszta; Sisareuth Tan; Andreea Milasan; Sara Michel; Abderrahim Benmoussa; Tania Lévesque; Francine Côté; Steven E McKenzie; Caroline Gilbert; Patrick Provost; Alain R Brisson; Alisa S Wolberg; Paul R Fortin; Catherine Martel; Éric Boilard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-02-27       Impact factor: 8.311

Review 9.  Advances in the pathophysiology and treatment of heparin-induced thrombocytopenia.

Authors:  Steven E McKenzie; Bruce S Sachais
Journal:  Curr Opin Hematol       Date:  2014-09       Impact factor: 3.284

10.  Direct interaction of kindlin-3 with integrin αIIbβ3 in platelets is required for supporting arterial thrombosis in mice.

Authors:  Zhen Xu; Xue Chen; Huiying Zhi; Juan Gao; Katarzyna Bialkowska; Tatiana V Byzova; Elzbieta Pluskota; Gilbert C White; Junling Liu; Edward F Plow; Yan-Qing Ma
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-26       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.